1997
DOI: 10.1016/s0027-5107(97)00004-3
|View full text |Cite
|
Sign up to set email alerts
|

Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
10
0

Year Published

1998
1998
2011
2011

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(12 citation statements)
references
References 30 publications
2
10
0
Order By: Relevance
“…This hypothesis is also supported by another study, in which MMS could induce liver micronuclei only in conjunction with partial hepatectomy [Tates and den Engelse, 1989]. Recently, Shane [1997] reported that a partial hepatectomy together with B[a]P treatment result in a modest increase in the mutation frequency (2.2-fold), although that was not statistically different from that of B[a]P treatment without a partial hepatectomy. In bacterial and even experiments in tissue culture, the clonality in analyzing mutations is readily avoided by using numerous small cultures and taking only a single mutant from each.…”
Section: The Question Of Clonalitysupporting
confidence: 56%
“…This hypothesis is also supported by another study, in which MMS could induce liver micronuclei only in conjunction with partial hepatectomy [Tates and den Engelse, 1989]. Recently, Shane [1997] reported that a partial hepatectomy together with B[a]P treatment result in a modest increase in the mutation frequency (2.2-fold), although that was not statistically different from that of B[a]P treatment without a partial hepatectomy. In bacterial and even experiments in tissue culture, the clonality in analyzing mutations is readily avoided by using numerous small cultures and taking only a single mutant from each.…”
Section: The Question Of Clonalitysupporting
confidence: 56%
“…The mutagenicity of B[a]P has previously been determined in the liver, spleen, forestomach, and bone marrow using oral administration or i.p. injection in the Big Blue mouse [Skopek et al, 1996;Shane et al, 1997Shane et al, , 2000, Muta Mouse [Mientjes et al, 1996;Rompelberg et al, 1996;Hakura et al, 1998;Kosinska et al, 1999], and the rpsL transgenic mouse [Muto et al, 1999]. In these reports, the authors did not determine whether the mutant frequency depended on the dose of B[a]P except for one study using spleen T-cells [Skopek et al, 1996].…”
Section: Discussionmentioning
confidence: 99%
“…Genomic DNA was isolated from the spleen of offspring identified as lacI carriers, according to a previously described protocol [Shane et al, 1997]. Subsequently, DNA was also isolated from the kidney, liver, and ovary or testis of those mice with a high mutant frequency in the spleen.…”
Section: Purification Of Genomic Dna For Laci Mutation Analysismentioning
confidence: 99%